Sreenivasamurthy Sai, Laul Mahek, Zhao Nan, Kim Tiffany, Zhu Donghui
Department of Biomedical Engineering Stony Brook University Stony Brook New York USA.
Institute for Nanobiotechnology Johns Hopkins University Baltimore Maryland USA.
Bioeng Transl Med. 2022 Aug 2;8(2):e10378. doi: 10.1002/btm2.10378. eCollection 2023 Mar.
Alzheimer's disease (AD) is a progressive, neurodegenerative disease that has emerged as a leading risk factor for dementia associated with increasing age. Two-dimensional (2D) cell culture and animal models, which have been used to analyze AD pathology and search for effective treatments for decades, have significantly contributed to our understanding of the mechanism of AD. Despite their successes, 2D and animal models can only capture a fraction of AD mechanisms due to their inability to recapitulate human brain-specific tissue structure, function, and cellular diversity. Recently, the emergence of three-dimensional (3D) cerebral organoids using tissue engineering and induced pluripotent stem cell technology has paved the way to develop models that resemble features of human brain tissue more accurately in comparison to prior models. In this review, we focus on summarizing key research strategies for engineering in vitro 3D human brain-specific models, major discoveries from using AD cerebral organoids, and its future perspectives.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,已成为与年龄增长相关的痴呆症的主要危险因素。二维(2D)细胞培养和动物模型已被用于分析AD病理学并寻找有效治疗方法数十年,它们为我们理解AD机制做出了重大贡献。尽管取得了成功,但二维和动物模型只能捕捉到AD机制的一部分,因为它们无法重现人类大脑特有的组织结构、功能和细胞多样性。最近,利用组织工程和诱导多能干细胞技术构建的三维(3D)脑类器官的出现,为开发比以往模型更准确地模拟人类脑组织特征的模型铺平了道路。在这篇综述中,我们重点总结了工程化体外3D人脑特异性模型的关键研究策略、使用AD脑类器官的主要发现及其未来前景。